Winner Deferred Long Term Liab from 2010 to 2024
| 300888 Stock | 40.38 3.18 8.55% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 152.6 M | Current Value 133.6 M | Quarterly Volatility 51 M |
Check Winner Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Winner Medical's main balance sheet or income statement drivers, such as Tax Provision of 222.6 M, Net Interest Income of 73 M or Interest Income of 140.6 M, as well as many indicators such as . Winner financial statements analysis is a perfect complement when working with Winner Medical Valuation or Volatility modules.
Winner | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Winner Stock
Winner Medical financial ratios help investors to determine whether Winner Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Winner with respect to the benefits of owning Winner Medical security.